TIAA CREF Investment Management’s XBiotech XBIT Stock Holding History

TIAA CREF Investment Management’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-45,676	Closed	-$244K	–	3121
2018 Q1	$244K	Hold	45,676	–	–	﹤0.01%	2947
2017 Q4	$180K	Hold	45,676	–	–	﹤0.01%	3010
2017 Q3	$200K	Buy	45,676 +2,243	+5%	+$10.6K	﹤0.01%	3043
2017 Q2	$204K	Hold	43,433	–	–	﹤0.01%	3086
2017 Q1	$716K	Sell	43,433 -1,822	-4%	-$23.9K	﹤0.01%	2668
2016 Q4	$458K	Sell	45,255 -4,269	-9%	-$56.8K	﹤0.01%	2878
2016 Q3	$667	Buy	49,524 +1,599	+3%	+$23.5K	﹤0.01%	2737
2016 Q2	$1M	Buy	47,925 +35,331	+281%	+$510K	﹤0.01%	2506
2016 Q1	$119K	Hold	12,594	–	–	﹤0.01%	3024
2015 Q4	$137K	Hold	12,594	–	–	﹤0.01%	3091
2015 Q3	$188K	Hold	12,594	–	–	﹤0.01%	3050
2015 Q2	$228K	Buy	+12,594	New	+$261K	﹤0.01%	3106

Other funds holding XBIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TIAA CREF Investment Management's XBIT Position: Q2 2018 in Review

TIAA CREF Investment Management sold out of XBiotech (XBIT) in Q2 2018, closing a stake of 45,676 shares — an estimated $244K sold.

TIAA CREF Investment Management first reported a position in XBIT in Q2 2015 and held it in 12 quarters. The position peaked at $1M in Q2 2016. 31 funds tracked by Wall St. Rank hold XBIT as of Q2 2018.

TIAA CREF Investment Management reported no remaining XBiotech position as of Q2 2018 after selling out during the quarter.
TIAA CREF Investment Management sold 45,676 XBiotech shares in Q2 2018, an estimated $244K.
TIAA CREF Investment Management first reported a position in XBiotech in Q2 2015 and held it in 12 quarters.
TIAA CREF Investment Management's XBiotech position peaked at $1M in Q2 2016.
31 funds tracked by Wall St. Rank held XBiotech as of Q2 2018.

Based on TIAA CREF Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.